[HTML][HTML] Energy metabolism disorders and potential therapeutic drugs in heart failure
Y He, W Huang, C Zhang, L Chen, R Xu, N Li… - … Pharmaceutica Sinica B, 2021 - Elsevier
Heart failure (HF) is a global public health problem with high morbidity and mortality. A large
number of studies have shown that HF is caused by severe energy metabolism disorders …
number of studies have shown that HF is caused by severe energy metabolism disorders …
Relaxin-2 as a potential biomarker in cardiovascular diseases
A Aragón-Herrera, S Feijóo-Bandín… - Journal of personalized …, 2022 - mdpi.com
The pleiotropic hormone relaxin-2 plays a pivotal role in the physiology and pathology of the
cardiovascular system. Relaxin-2 exerts relevant regulatory functions in cardiovascular …
cardiovascular system. Relaxin-2 exerts relevant regulatory functions in cardiovascular …
[HTML][HTML] Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice
Background The peptide hormone relaxin has potent anti-fibrotic and anti-inflammatory
properties in various organs, including the kidneys. However, the protective effects of relaxin …
properties in various organs, including the kidneys. However, the protective effects of relaxin …
Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling
T Devarakonda, J Valle Raleigh, AG Mauro… - Scientific Reports, 2022 - nature.com
Relaxin is a pleiotropic hormone demonstrated to confer cardioprotection in animal models
of myocardial infarction and ischemic heart failure by modulating inflammation, fibrosis and …
of myocardial infarction and ischemic heart failure by modulating inflammation, fibrosis and …
Therapeutic effects of Aconiti Lateralis Radix Praeparata combined with Zingiberis Rhizoma on doxorubicin-induced chronic heart failure in rats based on an …
JX Wen, RS Li, J Wang, JJ Hao, WH Qin… - Journal of Pharmacy …, 2020 - academic.oup.com
Objectives This study was aimed to explore the mechanism of Aconiti Lateralis Radix
Praeparata (ALRP) and Zingiberis Rhizoma (ZR) on doxorubicin (DOX)-induced chronic …
Praeparata (ALRP) and Zingiberis Rhizoma (ZR) on doxorubicin (DOX)-induced chronic …
Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes
AG Devasia, M Shanmugham, A Ramasamy… - Biochemical …, 2024 - Elsevier
Diabetes mellitus is a metabolic disease with an escalating global prevalence. Despite the
abundance and relative efficacies of current therapeutic approaches, they primarily focus on …
abundance and relative efficacies of current therapeutic approaches, they primarily focus on …
Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue
A Aragón-Herrera, S Feijóo-Bandín… - Biochemical …, 2024 - Elsevier
Abstract Recombinant human relaxin-2 (serelaxin) has been widely proven as a novel drug
with myriad effects at different cardiovascular levels, which support its potential therapeutic …
with myriad effects at different cardiovascular levels, which support its potential therapeutic …
Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension
P Chunduri, SA Patel, SP Levick - Advances in Pharmacology, 2022 - Elsevier
The pregnancy related hormone relaxin is produced throughout the reproductive system.
However, relaxin also has important cardiovascular effects as part of the adaptation that the …
However, relaxin also has important cardiovascular effects as part of the adaptation that the …
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
A Aragón‐Herrera, S Feijóo‐Bandín… - The FASEB …, 2021 - Wiley Online Library
Relaxin is an insulin‐like hormone with pleiotropic protective effects in several organs,
including the liver. We aimed to characterize its role in the control of hepatic metabolism in …
including the liver. We aimed to characterize its role in the control of hepatic metabolism in …
Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus
O Pankova, O Korzh - Wiener Medizinische Wochenschrift, 2024 - Springer
Background This study aimed to evaluate plasma relaxin‑2 (RLN-2) levels in patients with
arterial hypertension (AH) and their relationships with clinical and laboratory parameters …
arterial hypertension (AH) and their relationships with clinical and laboratory parameters …